Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

Pfizer’s abrupt withdrawal of Oxbryta, a drug for sickle cell disease, has sent shockwaves through the medical community.

The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

Significant regulatory news last week included the US Food and Drug Administration (FDA) granting approval for Zevra ...

Patricia McGill is among the oldest people in the U.S. with sickle cell disease, and she attributes her longevity to optimism ...